Trial Profile

Double-Blind, Randomised, Placebo-Controlled, Parallel Group Study to Evaluate the Interaction Between a Drug and CNV1014802 in Healthy Subjects

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 18 Oct 2017

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Vixotrigine (Primary)
Indications Neuropathic pain; Trigeminal neuralgia
Focus Adverse reactions; Pharmacokinetics
Sponsors Convergence Pharmaceuticals

Most Recent Events

04 May 2017 Status changed from active, no longer recruiting to completed.
18 Sep 2015 New trial record
24 Apr 2015 This trial was planned by Convergence. The Company has now been acquired by Biogen, according to Biogen media release.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com